Zobrazeno 1 - 10
of 142
pro vyhledávání: '"Kentaro, Fukushima"'
Autor:
Satoshi Uchiyama, Kentaro Fukushima, Seiichiro Katagiri, Junichi Tsuchiya, Tomohiro Kubo, SungGi Chi, Yosuke Minami
Publikováno v:
Therapeutic Advances in Hematology, Vol 15 (2024)
The identification of chromosomal abnormalities accompanied by copy number alterations is important for understanding tumor characteristics. Testing methodologies for copy number abnormality have limited sensitivity, resulting in their use only for t
Externí odkaz:
https://doaj.org/article/7c3d9a6b5fb8478f9357f933dbdf0446
Autor:
Maiko Naito, Kentaro Fukushima, Shinsuke Kusakabe, Takaya Endo, Takayuki Shiroyama, Kika Ohira, Koji Azuma, Satoshi Tanizaki, Yumiko Yamamoto, Yuki Hosono, Yujiro Naito, Shinji Futami, Kotaro Miyake, Haruhiko Hirata, Yoshito Takeda, Atsushi Kumanogoh
Publikováno v:
BMC Infectious Diseases, Vol 23, Iss 1, Pp 1-5 (2023)
Abstract Background Mycobacterium obuense (M. obuense) is a rapidly growing mycobacterium (RGM) which has been considered nonpathogenic. Here, we report a case of disseminated non-tuberculous mycobacterial (NTM) infection caused by M. obuense in an i
Externí odkaz:
https://doaj.org/article/633c8a6e91a54901960bb929d833b853
Autor:
Yutaka Shimazu, Junya Kanda, Satoru Kosugi, Tomoki Ito, Hitomi Kaneko, Kazunori Imada, Yuji Shimura, Shin-ichi Fuchida, Kentaro Fukushima, Hirokazu Tanaka, Satoshi Yoshihara, Kensuke Ohta, Nobuhiko Uoshima, Hideo Yagi, Hirohiko Shibayama, Ryosuke Yamamura, Yasuhiro Tanaka, Hitoji Uchiyama, Yoshiyuki Onda, Yoko Adachi, Hitoshi Hanamoto, Ryoichi Takahashi, Mitsuhiro Matsuda, Takashi Miyoshi, Teruhito Takakuwa, Masayuki Hino, Naoki Hosen, Shosaku Nomura, Chihiro Shimazaki, Itaru Matsumura, Akifumi Takaori-Kondo, Junya Kuroda
Publikováno v:
Scientific Reports, Vol 13, Iss 1, Pp 1-12 (2023)
Abstract Novel therapeutic drugs have dramatically improved the overall survival of patients with multiple myeloma. We sought to identify the characteristics of patients likely to exhibit a durable response to one such drug, elotuzumab, by analyzing
Externí odkaz:
https://doaj.org/article/f9f360c7a7b8496ea74ce32ada6c5c4d
Autor:
Kayako Isohashi, Yasukazu Kanai, Teruhito Aihara, Naonori Hu, Kentaro Fukushima, Ichiro Baba, Fumitoshi Hirokawa, Ryo Kakino, Tsuyoshi Komori, Keiji Nihei, Jun Hatazawa, Koji Ono
Publikováno v:
European Journal of Hybrid Imaging, Vol 6, Iss 1, Pp 1-13 (2022)
Abstract Background The goal of the study was to evaluate the diagnostic ability of 18F-FBPA PET/CT for malignant tumors. Findings from 18F-FBPA and 18F-FDG PET/CT were compared with pathological diagnoses in patients with malignant tumors or benign
Externí odkaz:
https://doaj.org/article/ccc0168c7db848b5b7910220ea82a4b3
Autor:
Tomohiko Ikehara, Tadaaki Shimizu, Shohei Hirano, Kentaro Fukushima, Jun-ichi Yoshizawa, Toshitsugu Nakamura, Ataru Nakayama
Publikováno v:
Surgical Case Reports, Vol 8, Iss 1, Pp 1-8 (2022)
Abstract Background It has been reported that hepatocellular carcinoma (HCC) with spindle cell tumor accounts for 1.8% of all HCCs, but spindle cell tumors that do not show an obvious conventional HCC are extremely rare. In this report, we describe a
Externí odkaz:
https://doaj.org/article/8b6e8350670443219f0547e570ac68c7
Autor:
Akihisa Hino, Kentaro Fukushima, Shinsuke Kusakabe, Tomoaki Ueda, Takao Sudo, Jiro Fujita, Daisuke Motooka, Takafumi Yokota, Hirohiko Shibayama, Shota Nakamura, Naoki Hosen
Publikováno v:
HemaSphere, Vol 7, p e245098c (2023)
Externí odkaz:
https://doaj.org/article/8b337b5172334435a0f434c2392d39f6
Autor:
Kentaro Fukushima, Hayami Kudo, Kentaro Oka, Atsushi Hayashi, Makoto Onizuka, Shinsuke Kusakabe, Akihisa Hino, Motomichi Takahashi, Kiyoshi Takeda, Masaki Mori, Kiyoshi Ando, Naoki Hosen
Publikováno v:
HemaSphere, Vol 7, p e200988b (2023)
Externí odkaz:
https://doaj.org/article/dceaf68530494f41b1d4c497a3776c92
Autor:
Aya Nakaya, Hirohiko Shibayama, Nobuhiko Uoshima, Ryosuke Yamamura, Satoshi Yoshioka, Kazunori Imada, Yuji Shimura, Masaaki Hotta, Toshimitsu Matsui, Satoru Kosugi, Hitoshi Hanamoto, Hitoji Uchiyama, Satoshi Yoshihara, Shin-ichi Fuchida, Yoshiyuki Onda, Yasuhiro Tanaka, Kensuke Ohta, Mitsuhiro Matsuda, Junya Kanda, Adachi Yoko, Miki Kiyota, Eri Kawata, Ryoichi Takahashi, Kentaro Fukushima, Hirokazu Tanaka, Hideo Yagi, Teruhito Takakuwa, Naoki Hosen, Tomoki Ito, Chihiro Shimazaki, Akifumi Takaori-Kondo, Junya Kuroda, Itaru Matsumura, Masayuki Hino
Publikováno v:
Leukemia Research Reports, Vol 20, Iss , Pp 100395- (2023)
To evaluate the specific prognostic value of CAs, we conducted an analysis of 923 symptomatic multiple myeloma patients. Among this cohort, 480 patients had complete data set of high-risk CAs by interphase fluorescent in situ hybridization at diagnos
Externí odkaz:
https://doaj.org/article/82b016d7b6d64623a8db970348a6c492
Autor:
Yutaka Shimazu, Junya Kanda, Hitomi Kaneko, Kazunori Imada, Ryosuke Yamamura, Satoru Kosugi, Yuji Shimura, Tomoki Ito, Shin-ichi Fuchida, Hitoji Uchiyama, Kentaro Fukushima, Satoshi Yoshihara, Hitoshi Hanamoto, Hirokazu Tanaka, Nobuhiko Uoshima, Kensuke Ohta, Hideo Yagi, Hirohiko Shibayama, Yoshiyuki Onda, Yasuhiro Tanaka, Yoko Adachi, Mitsuhiro Matsuda, Masato Iida, Takashi Miyoshi, Toshimitsu Matsui, Ryoichi Takahashi, Teruhito Takakuwa, Masayuki Hino, Naoki Hosen, Shosaku Nomura, Chihiro Shimazaki, Itaru Matsumura, Akifumi Takaori-Kondo, Junya Kuroda
Publikováno v:
Therapeutic Advances in Hematology, Vol 13 (2022)
Background: Daratumumab is one of the most widely used treatments for relapsed/refractory multiple myeloma (MM) patients. However, not all patients achieve a lasting therapeutic response with daratumumab. Objectives: We hypothesized that a durable re
Externí odkaz:
https://doaj.org/article/de0e47159d65497ba083e4d809b5a35a
Autor:
Kenji Nozaki, Takafumi Yokota, Eri Itotagawa, Kazuhito Tsutsumi, Shinsuke Kusakabe, Yoichiro Morikawa, Jiro Fujita, Kentaro Fukushima, Tetsuo Maeda, Hirohiko Shibayama, Naoki Hosen, Atsushi Kumanogo, Yuzuru Kanakura
Publikováno v:
Clinical Case Reports, Vol 8, Iss 11, Pp 2251-2254 (2020)
Abstract We believe that our report and further case reports on T‐cell chronic lymphocytic leukemia with genetic profile will contribute to the molecular classification of this rare but distinct disease.
Externí odkaz:
https://doaj.org/article/678bcedaa85843b4bef2e145f2e30e25